News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Job Trends
Gilead Sciences, Inc. To Close Down Durham Office; Phase Out 150 Jobs
June 25, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Triangle Business Journal -- Gilead Sciences (Nasdaq: GILD) will close its Durham office by year’s end in a move affecting 150 workers, as the Foster City, Calif-based bio-sciences company consolidates in anti-viral research and development efforts.
Twitter
LinkedIn
Facebook
Email
Print
Job creations
Gilead Sciences, Inc.
MORE ON THIS TOPIC
Job Trends
Biopharma professionals increasingly accept underemployment
May 21, 2026
·
5 min read
·
Angela Gabriel
Job Trends
Takeda cuts send layoffs soaring in May, rising year over year
May 19, 2026
·
4 min read
·
Angela Gabriel
Layoff Tracker
Takeda cuts 4,500, Novartis lays off biomedical research staff
May 15, 2026
·
54 min read
·
BioSpace Editorial Staff
Job Trends
Employment and funding growth fell in 2025: California Life Sciences report
May 15, 2026
·
2 min read
·
Angela Gabriel